SCHEMBL10378565

SCHEMBL10378565

Cc1[nH]c(=O)ccc1C(=O)c1ccc(O)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.47
▸ LMNA P02545 4/20 0.47
▸ HPGD P15428 3/20 0.47
▸ HTT P42858 2/20 0.47
▸ ESR1 P03372 2/20 0.47
▸ ESR2 Q92731 2/20 0.47
▸ PKM P14618 1/20 0.47
▸ ALDH1A1 P00352 3/20 0.45
▸ TDP1 Q9NUW8 2/20 0.45
▸ MAPK1 P28482 2/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ RECQL P46063 1/20 0.45
▸ HSD17B10 Q99714 1/20 0.45
▸ LIG1 P18858 1/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ POLB P06746 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ SRD5A2 P31213 1/20 0.41
▸ KMT2A Q03164 4/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10377556 0.88 ALDH1A1 (0.52) MAPTLMNAHPGDALDH1A1TDP1
SCHEMBL10378678 0.85 GRM5 (0.43) MAPTLMNAALDH1A1TDP1SMN1; SMN2
SCHEMBL10378571 0.85 NR4A1 (0.45) MAPTHPGDPKMMAPK1POLB
SCHEMBL10377589 0.85 MAPT (0.46) MAPTLMNAHPGDHTTMAPK1
SCHEMBL10378560 0.84 MAPT (0.47) MAPTLMNAHPGDHTTPKM
SCHEMBL10377414 0.82 PLK1 (0.45) MAPTLMNAHPGDHTTALDH1A1
SCHEMBL10377417 0.82 NPC1 (0.54) MAPTLMNAHPGDHTTALDH1A1
SCHEMBL10377855 0.81 CA1 (0.42) MAPTESR1PKMALDH1A1CYP3A4
SCHEMBL10378895 0.80 MAPT (0.50) MAPTLMNAHTTALDH1A1TDP1
SCHEMBL10377444 0.79 KDM4E (0.56) MAPTLMNAHPGDALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4560691-A 5-(Phenyl)-1,6-naphthyridin-2(1H)-ones, their cardiotonic use and preparation STERLING DRUG INC. (US) 1985-12-24 — — US claimed
EP-0168037-B1 1-6-NAPHTHYRIDIN-2(1H)-ONES USEFUL AS CARDIOTONICS STERLING DRUG INC. (US) 1990-02-07 — — EP disclosed
EP-0168037-A2 1-6-Naphthyridin-2(1H)-ones useful as cardiotonics STERLING DRUG INC. (US) 1986-01-15 — — EP disclosed
US-4560691-A 5-(Phenyl)-1,6-naphthyridin-2(1H)-ones, their cardiotonic use and preparation STERLING DRUG INC. (US) 1985-12-24 — — US disclosed
Send feedback